Advanced Enzyme Technologies Ltd share price logo

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES

BSE: 540025

Small Cap

Pharma Sector

₹288.00

+0.30

(+0.10%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Advanced Enzyme Technologies shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-48%

Searches for Advanced Enzyme Technologies on INDmoney have decreased by 48% over the last 30 days.

Average holding period of indmoney investors

43 days

INDmoney investors hold Advanced Enzyme Technologies shares for an average of 43 days.

Key Events for Advanced Enzyme Technologies

Last Dividend Declared

₹1.35 per share, declared on 09/05/2026

View Dividend History

Advanced Enzyme Technologies Stock Performance

as on September 16, 2026 at 8:56 pm IST

  • Day's Low

    Day's High

    ₹282.05
    ₹293.20
    downward going graph

    2.07%

    Downside

    1.81%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹251.95
    ₹419.00
    downward going graph

    12.52%

    Downside

    45.49%

    Upside

    downward going graph

Advanced Enzyme Technologies share price movements today

Previous Close
₹287.70
Open
₹288.00
Volume
1.74L
Upper Circuit
₹345.20
Lower Circuit
₹230.20
Day's Low - High
₹282.05 - ₹293.20
52 Week Low - High
₹251.95 - ₹419.00

Advanced Enzyme Technologies Historical Returns

1 Month Return
-5.86 %
3 Month Return
-21.94 %
1 Year Return
-16.64 %
3 Year Return
-8.05 %
5 Year Return
-26.27 %

Advanced Enzyme Technologies Fundamentals

as on September 16, 2026 at 3:26 pm IST

Market Cap

₹3,221.55 Cr

Return on Equity (ROE)

19.69

PE Ratio (TTM)

19.8

Return on capital employed (ROCE)

23.45

Industry PE ratio

51.81

Beta (LTM)

0.99

P/B Ratio

4.03

Dividend Yield

2.1

PEG Ratio

7.67

Quarterly Earnings Growth YOY

-4.57

EPS (TTM)

15.51

Book Value

145.79

Advanced Enzyme Technologies Stock Valuation

as on September 16, 2026 at 3:26 pm IST

Advanced Enzyme Technologies in the last 5 years

  • Overview

  • Trends

Lowest (8.53x)

March 23, 2020

Today (19.80x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (44.35x)

September 16, 2024

LowHigh

Today’s Price to Earnings Ratio: 19.80x

Advanced Enzyme Technologies Technical Analysis

Track how Advanced Enzyme Technologies technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish10
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
0.04
Bullish
CCI (20)
-83.56
Neutral
RSI (14)
54.65
Neutral
Momentum (10)
0.25
Bullish
ADI (14)
16.98
Neutral
Ultimate Oscillator (7,14,28)
52.77
Neutral

Moving Averages

Name

Value

Action

SMA (20)
287.87
Bullish
EMA (20)
287.84
Bullish
VWMA (20)
287.85
Bullish
SMA (50)
287.77
Bullish
EMA (50)
287.77
Bullish
SMA (200)
287.96
Bullish
EMA (200)
288.06
Bearish
KAMA (200)
287.55
Bullish
DEMA (200)
287.34
Bullish

Advanced Enzyme Technologies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Advanced Enzyme Technologies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Advanced Enzyme Technologies Ltd image
Advanced Enzyme Technologies Ltd
BUY3,221.55-5.25%0.53173745
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Market expectation of Advanced Enzyme Technologies Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Advanced Enzyme Technologies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
157.84
160.94
157.82
154.52
146.1
169.11
167.18
185.91
184.53
171.95
203.37
189.79
Other Income
6.1
14.4
9.5
6.99
9.62
7.69
8.75
8.85
10.28
19.72
7.34
13.02
Total Income
163.94
175.33
167.31
161.52
155.71
176.8
175.92
194.76
194.81
191.66
210.71
202.81
Expenses
106.53
107.17
117.58
103.36
103.68
113.86
121.58
129.48
124.47
122.6
140.14
138.82
Operating Profit
51.31
53.77
40.24
51.16
42.42
55.25
45.6
56.43
60.06
49.35
63.23
50.97
Operating Profit Margin %
32.51%
33.41%
25.5%
33.11%
29.03%
32.67%
27.28%
30.35%
32.55%
28.7%
31.09%
26.86%
Profit Before Interest, Tax and Depreciation
57.41
68.16
49.74
58.16
52.03
62.94
54.35
65.28
70.34
69.07
70.57
63.99
Interest
0.75
0.68
0.85
0.87
0.93
0.94
0.81
0.76
0.72
0.57
0.57
0.58
Depreciation
8.73
8.6
9.28
8.61
8.9
8.97
10.08
9.62
10.08
10.21
10.19
9.88
Profit Before Tax
47.93
58.88
39.61
48.68
42.2
53.03
43.46
54.9
59.54
58.29
59.81
53.53
Tax Paid
12.73
16.38
9.74
13.7
8.81
14.14
16.73
14.46
14.81
15.11
14.55
14.94
Profit After Tax
35.2
42.5
29.87
34.98
33.39
38.88
26.73
40.44
44.73
43.18
45.25
38.59
Total Net profit including share of profit / Loss from associate company
35.2
42.5
29.87
34.98
33.39
38.88
26.73
40.44
44.73
43.18
45.25
38.59
EPS
3.08
3.74
2.53
3.05
2.94
3.36
2.37
3.57
3.87
3.8
3.84
3.31
Actual EPS
3.08
3.74
2.53
3.05
2.94
3.36
2.37
3.57
3.87
3.8
3.84
3.31
Adjusted EPS
3.08
3.74
2.53
3.05
2.94
3.36
2.37
3.57
3.87
3.8
3.84
3.31
Diluted EPS
3.08
3.74
2.53
3.05
2.93
3.36
2.37
3.57
3.87
3.79
3.84
3.31

Advanced Enzyme Technologies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
391.02
419.59
443.99
501.84
529.38
540.64
623.87
636.91
745.76
Other Income
1.39
5.04
5.64
8.85
6.42
25.46
36.66
33.04
46.19
Total Income
392.41
424.63
449.63
510.69
535.8
566.09
660.53
669.95
791.95
Expenses
227.06
237.68
241.66
270.23
327.97
388.26
434.54
442.47
516.69
Operating Profit
163.96
181.91
202.33
231.61
201.41
152.38
189.33
194.44
229.07
Operating Profit Margin %
41.93%
43.35%
45.57%
46.15%
38.05%
28.19%
30.35%
30.53%
30.72%
Profit Before Interest, Tax and Depreciation
165.35
186.95
207.97
240.46
207.84
177.84
225.99
227.48
275.26
Interest
8.09
3.87
3.04
1.61
1.8
2.42
2.93
3.56
2.63
Depreciation
18.3
21.12
25.78
28.72
34.98
35.03
35.24
36.56
40.09
Profit Before Tax
138.96
161.96
179.15
210.13
171.06
140.39
187.82
187.36
232.54
Tax Paid
45.41
46.06
46.11
58.85
47.26
36.52
50.87
53.39
58.93
Profit After Tax
93.56
115.9
133.05
151.29
123.8
103.87
136.95
133.97
173.61
Total Net profit including share of profit / Loss from associate company
93.56
115.9
133.05
151.29
123.8
103.87
136.95
133.97
173.61
EPS
8.07
9.95
11.58
13.06
10.7
9.45
11.92
11.72
15.08
Actual EPS
8.07
9.95
11.58
13.06
10.7
9.45
11.92
11.72
15.08
Adjusted EPS
8.07
9.95
11.58
13.06
10.7
9.45
11.92
11.72
15.08
Diluted EPS
8.06
9.94
11.56
13.04
10.68
9.45
11.92
11.71
15.06

Advanced Enzyme Technologies Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
93.4
107.35
115.98
128.57
140.9
162.89
122.29
140.36
141.37
142.5
156.78
Cash Flow from Investing Activities
-9.74
-59.8
-58.95
-123.54
-42.75
-27.33
1.64
-285.5
-59.85
-89.48
-71.87
Cash Flow from Financing Activities
-62.58
-65.3
-2.07
-43.1
-38.55
-26.32
-48.52
-25.8
-59.25
-72.54
-70.37
Net Cash Flow
21.09
-17.76
53.62
-38.07
59.6
109.26
75.44
-170.94
17.33
-19.53
14.53

Advanced Enzyme Technologies Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
43.62%
43.49%
43.02%
42.95%
42.93%
43.08%
43.08%
43.07%
43.04%
43.26%
43.24%
DII
5.42%
7.56%
8.08%
8.02%
8.18%
8.19%
8.45%
6.41%
5.51%
5.41%
4.78%
FII
0%
23.01%
12.03%
12.63%
12.58%
11.9%
23.46%
25.41%
25.86%
25.49%
26.71%
Public
26.86%
25.94%
36.87%
36.41%
36.32%
36.83%
25.02%
25.1%
25.59%
25.84%
25.27%
Total Outstanding Shares
11,18,24,075
11,18,24,075
11,18,24,075
11,18,24,075
11,18,80,650
11,18,81,150
11,18,81,150
11,18,81,150
11,19,26,800
11,19,26,800
11,19,76,150
Total Shareholders
73,034
68,640
65,222
66,758
67,351
65,322
67,589
69,637
68,051
66,193
63,599

Mutual Funds Buying / Exiting Advanced Enzyme Technologies

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Advanced Enzyme Technologies

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Advanced Enzyme Technologies

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

ICICI Prudential ESG Exclusionary Strategy Fund Direct Growth

ICICI Prudential ESG Exclusionary Strategy Fund Direct Growth

₹18.86 Cr

₹4.73 Cr (-20.06%)

1.42%

Advanced Enzyme Technologies Corporate Actions

View detailed summary of the earnings and dividend history of Advanced Enzyme Technologies.

  • Advanced Enzyme Technologies Ltd Earnings Results

    Advanced Enzyme Technologies Ltd’s net profit fell -7.11% since last year same period to ₹37.09Cr in the Q1 2026-2027. On a quarterly growth basis, Advanced Enzyme Technologies Ltd has generated -13.66% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Advanced Enzyme Technologies Ltd Dividends May,2026

    In the quarter ending March 2026, Advanced Enzyme Technologies Ltd has declared dividend of ₹1.35 per share on 09 May 2026 - translating a dividend yield of 0.46%.

    Read More about Dividends

Indices Featuring Advanced Enzyme Technologies Stock

Check stock indices that include Advanced Enzyme Technologies.

BSE Healthcare

₹50,388.55

-90.26 (▲0.18%)

Insights on Advanced Enzyme Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 13.42% to 14.64% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Privi Speciality Chemicals Ltd has given 184.9% return, outperforming this stock by 193.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Aether Industries Ltd has given 115.4% return, outperforming this stock by 132.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ADVENZYMES stock has moved down by -21.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 42.96 Cr → 37.09 Cr (in ₹), with an average decrease of 13.7% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 43.26% to 43.24% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 210.71 Cr → 202.81 Cr (in ₹), with an average decrease of 3.8% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.84% to 25.27% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.93% to 1.82% in Jun 2026 quarter

About Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Limited AETL is the largest Indian enzyme company and is engaged in research, development, manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. With state-of-the-art facilities in India, Germany and USA, it has transitioned the business and transformed the sector. AETL, formerly Advanced Biochemicals Limited, was established in 1989. In 2011, the company acquired CalIndia Foods International and in 2012 it acquired Advanced Supplementary Technologies Corporation. In 2016, the company came up with an Initial Public Offer (IPO) of 4594875 Equity shares of Rs 10 each which were subscribed 82.06 times. During the financial year ended 31 March 2017, AETL acquired 1.43 crore equity shares at Rs. 35 per share of JC Biotech Private Limited (JCB) and further acquired 200,000 equity shares and 150000 equity shares of MYR 1 of AEM. On July 11 2017, AETL incorporated a wholly owned subsidiary Advanced Enzymes Europe BV. On 3 October 2017, the company acquired certain assets and liabilities of Biomedic Labs and in January 2021 it completed 'the acquisition of controlling stake of 51 in SciTech Specialities Private Limited SSPL India'. On 29 May 2021 it acquired additional 15% stake of JCB. Overall on 31 March 2021, the company had 12 subsidiaries.

Revenue: ₹189.79Cr as on June 2026 (Q1 FY27)
Net Profit: ₹38.59Cr as on June 2026 (Q1 FY27)
Listing date: 01 Aug, 2016
Chairperson Name: VASANT RATHI
OrganisationAdvanced Enzyme Technologies Ltd
IndustryPharmaceuticals
CEOVASANT RATHI
E-voting on sharesClick here to vote

FAQs

What is Advanced Enzyme Technologies share price today?

Advanced Enzyme Technologies share price today stands at ₹288 as on . Advanced Enzyme Technologies share today touched a day high of ₹293.2 and a low of ₹282.05.

What is the 52 week high and 52 week low range for Advanced Enzyme Technologies share?

Advanced Enzyme Technologies touched a 52 week high of ₹419 and a 52 week low of ₹251.95. Advanced Enzyme Technologies share price today i.e. is trending at ₹288, which is -31.26% down from its 52 week high and 14.31% up from its 52 week low.

What is Advanced Enzyme Technologies's market capitalisation today?

Advanced Enzyme Technologies market capitalisation is ₹3,221.55 Cr as on .

How to buy Advanced Enzyme Technologies shares?

To buy Advanced Enzyme Technologies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ADVENZYMES or Advanced Enzyme Technologies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Advanced Enzyme Technologies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Advanced Enzyme Technologies trading volume today?

Advanced Enzyme Technologies trading volume is 1.74L as on . This means that 1.74L shares of Advanced Enzyme Technologies were bought and sold on the stock market during today's trading session.